|
MARKETWATCH
Direct-To-Consumer Advertisements For HIV Antiretroviral Medications: A Progress Report
Alexander Kallen,
Steven Woloshin,
Jennifer Shu,
Ellen Juhl and
Lisa Schwartz
Direct-to-consumer (DTC) prescription drug advertisements for HIV anti-retrovirals are controversial and have been criticized in the past for including deceptive images and underplaying HIV drug limitations. We sought to describe the state of recent DTC ads for HIV antiretrovirals in popular magazines by performing a content analysis of all complete DTC ads for antiretroviral medications appearing in eight national magazines during a one-year period. Current ads appear to have addressed previous concerns, but important problems still exist, such as failing to specify the medication’s role in current treatment, to quantify drug efficacy, or to highlight life-threatening side effects.
       What's this?
This article has been cited by other articles:
|
|
|
|
 
D. L. Frosch, D. Grande, D. M. Tarn, and R. L. Kravitz
A Decade of Controversy: Balancing Policy With Evidence in the Regulation of Prescription Drug Advertising
Am J Public Health,
January 1, 2010;
100(1):
24 - 32.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. M. Schwartz, S. Woloshin, and H. G. Welch
Using a Drug Facts Box to Communicate Drug Benefits and Harms: Two Randomized Trials
Ann Intern Med,
April 21, 2009;
150(8):
516 - 527.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
